A Programmed Drug‐Loaded and Penetration‐Delivery Functionalized Microneedle Patch for Synergistic Obesity Treatment
Advanced Healthcare Materials · 2026-08 · 15 (30)
DOI: 10.1002/adhm.71409 ↗At a glance
Journal article in Advanced Healthcare Materials, published online on 2026-07-06. Written by Feng Zeng and 6 co-authors. Institution: Research Center for Pharmaceutical Preparation and Nanomedicine Technology, College of Pharmacy, Chongqing Medical University, Chongqing, P. R. China. Major MEDLINE topics: Obesity, Drug Delivery Systems. Cited 1 times so far (Crossref); 65 references. The full text is freely available in PubMed Central. Funded by: Science and Technology Research Program of Chongqing Municipal Education Commission, TCM Vocational Education Project of Chinese Association of Traditional Chinese Medicine, Yang Bo National Master Traditional Pharmaceutical Craftsman Inheritance Studio.
Abstract (original language)
The inherent pathological microenvironment of adipose tissue restricts accumulation and deep penetration delivery of drugs, resulting in the lack of an ideal strategy for obesity management. In view of this, a dual‐layered microneedle system was developed for obesity treatment. Firstly, capsaicin (Cap) and mitochondrial uncoupler BAM15 were respectively co‐assembled with solutol HS‐15 (HS) to obtain functionalized nanodrugs (HS@Cap NPs or HS@BAM15 NPs). Then they were integrated into the microneedle system (BC‐MNs). The BC‐MNs realize programmed controlled release of nanodrugs in subcutaneous tissue via transdermal delivery. HS@Cap NPs rapidly release at the needle tip to penetrate deep white adipose tissue and promote its browning. Sequentially, slowly released HS@BAM15 NPs then accumulate in beige adipocytes to enhance cell metabolism, achieving synergistic anti‐obesity effects. Finally, both in vitro and in vivo experiments analyzed and validated the therapeutic efficacy of this system for obesity. In summary, the above‐mentioned cascade co‐treatment strategy based on the microneedle drug delivery system provides a potential possibility for clinical management and treatment of obesity.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Research Center for Pharmaceutical Preparation and Nanomedicine Technology, College of Pharmacy, Chongqing Medical University, Chongqing, P. R. China.
- Bishan Hospital, Chongqing University of Chinese Medicine, Chongqing, P. R. China.
- Weight Management Center, Bishan Hospital, Chongqing University of Chinese Medicine, Chongqing, P. R. China.
ORCID profiles: Zhangyou Yang
Funding
- Science and Technology Research Program of Chongqing Municipal Education Commission
- TCM Vocational Education Project of Chinese Association of Traditional Chinese Medicine
- Yang Bo National Master Traditional Pharmaceutical Craftsman Inheritance Studio
Cite
APA
Zeng, F., Liu, Q., Xiang, Y., Hu, H., Zheng, J., Yang, Z., & Tao, R. (2026). A Programmed Drug‐Loaded and Penetration‐Delivery Functionalized Microneedle Patch for Synergistic Obesity Treatment. Advanced Healthcare Materials, 15(30). https://doi.org/10.1002/adhm.71409
Vancouver
Zeng F, Liu Q, Xiang Y, Hu H, Zheng J, Yang Z, et al. A Programmed Drug‐Loaded and Penetration‐Delivery Functionalized Microneedle Patch for Synergistic Obesity Treatment. Advanced Healthcare Materials. 2026;15(30). doi:10.1002/adhm.71409
BibTeX
@article{Zeng2026,
author = {Zeng, Feng and Liu, Qi and Xiang, Yunqiang and Hu, Hui and Zheng, Junyao and Yang, Zhangyou and Tao, Rui},
title = {A Programmed Drug‐Loaded and Penetration‐Delivery Functionalized Microneedle Patch for Synergistic Obesity Treatment},
journal = {Advanced Healthcare Materials},
year = {2026},
volume = {15},
number = {30},
doi = {10.1002/adhm.71409}
}
EUVIMED